John McCafferty to Present Knotbody Technology at Biophysics Society Meeting, New Orleans

Posted 24 January 2017

Share this article:

Dr John McCafferty, founder and CEO of IONTAS Ltd, will be presenting the latest on ion channel blocking antibodies (KnotBodyTM Technology) at the Biophysics Society meeting in New Orleans (10th - 15th February 2017). The presentation will describe an antibody based drug discovery platform for generating therapeutics against ion channels. The technology leverages the benefits of antibody selectivity, specificity and stability whilst employing the ion channel blocking activities of a variety of naturally sourced toxins.